Page 49 - Mesenchymal Stem cells, Exosomes and vitamins in the fight aginst COVID

Al-Khawaga and Abdelalim Stem Cell Research & Therapy (2020) 11:437 Page 30 of 33

15. Hutchinson M, Tattersall RS, Manson JJ. Haemophagocytic 41. Patel SA, Sherman L, Munoz J, et al. Immunological properties of
lymphohisticytosis-an underrecognized hyperinflammatory syndrome. mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp.
Rheumatology (Oxford). 2019;58(Suppl 6):vi23–30. 2008;56(1):1–8.
16. Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: 42. Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to
implications for SARS. Nat Rev Immunol. 2005;5(12):917–27. allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and
17. Wong CK, Lam CW, Wu AK, et al. Plasma inflammatory cytokines and suppression. J Biomed Sci. 2005;12(1):47–57.
chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004; 43. Lian Q, Zhang Y, Zhang J, et al. Functional mesenchymal stem cells derived
136(1):95–103. from human induced pluripotent stem cells attenuate limb ischemia in
18. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 mice. Circulation. 2010;121(9):1113–23.
novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. 44. Cui L, Yin S, Liu W, et al. Expanded adipose-derived stem cells suppress
19. Yang Y, Shen C, Li J, et al. Plasma IP-10 and MCP-3 levels are highly mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng.
associated with disease severity and predict the progression of COVID-19. J 2007;13(6):1185–95.
Allergy Clin Immunol. 2020;146(1):119–27 e114. 45. Gotherstrom C, Ringden O, Tammik C, et al. Immunologic properties of human
20. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular fetal mesenchymal stem cells. Am J Obstet Gynecol. 2004;190(1):239–45.
Endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 46. Liu S, Yuan M, Hou K, et al. Immune characterization of mesenchymal stem
2020;383(2):120–8. cells in human umbilical cord Wharton's jelly and derived cartilage cells. Cell
21. Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 Immunol. 2012;278(1–2):35–44.
protein, the functional receptor for SARS coronavirus. A first step in 47. Chan WK, Lau AS, Li JC, et al. MHC expression kinetics and immunogenicity
understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7. of mesenchymal stromal cells after short-term IFN-gamma challenge. Exp
22. Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients Hematol. 2008;36(11):1545–55.
with tocilizumab. Proc Natl Acad Sci U S A. 2020;117(20):10970–5. 48. Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic
23. Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 properties of differentiated and undifferentiated mesenchymal stem cells.
blockade for cytokine storm. Immunotherapy. 2016;8(8):959–70. Exp Hematol. 2003;31(10):890–6.
24. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of 49. Sun YQ, Zhang Y, Li X, et al. Insensitivity of human iPS cells-derived
adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort mesenchymal stem cells to interferon-gamma-induced HLA expression
study. Lancet. 2020;395(10229):1054–62. potentiates repair efficiency of hind limb ischemia in immune humanized
25. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature NOD Scid gamma mice. Stem Cells. 2015;33(12):3452–67.
for MSC: the International Society for Cellular Therapy position statement. 50. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult
Cytotherapy. 2005;7(5):393–5. human mesenchymal stem cells. Science. 1999;284(5411):143–7.
26. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining 51. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose
multipotent mesenchymal stromal cells. The International Society for tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–28.
Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7. 52. Pittenger MF, Discher DE, Peault BM, et al. Mesenchymal stem cell
27. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22.
marrow. Analysis of precursor cells for osteogenic and hematopoietic 53. Pittenger MF. Mesenchymal stem cells from adult bone marrow. Methods
tissues. Transplantation. 1968;6(2):230–47. Mol Biol. 2008;449:27–44.
28. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal 54. Stolzing A, Jones E, McGonagle D, et al. Age-related changes in human
stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301–13. bone marrow-derived mesenchymal stem cells: consequences for cell
29. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of therapies. Mech Ageing Dev. 2008;129(3):163–73.
multipotent stem cells. Mol Biol Cell. 2002;13(12):4279–95. 55. Karam M, Younis I, Elareer NR, et al. Scalable heneration of mesenchymal
30. Gronthos S, Mankani M, Brahim J, et al. Postnatal human dental pulp stem stem cells and adipocytes from human pluripotent stem cells. Cells. 2020;
cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000;97(25): 9(3):710.
13625–30. 56. Karam M, Abdelalim EM. Robust and highly efficient protocol for
31. Young HE, Steele TA, Bray RA, et al. Human reserve pluripotent differentiation of human pluripotent stem cells into mesenchymal stem
mesenchymal stem cells are present in the connective tissues of skeletal cells. Methods Mol Biol. 2020: https://doi.org/10.1007/7651_2020_318.
muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec. 57. Krasnodembskaya A, Song Y, Fang X, et al. Antibacterial effect of human
2001;264(1):51–62. mesenchymal stem cells is mediated in part from secretion of the
32. Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchymal antimicrobial peptide LL-37. Stem Cells. 2010;28(12):2229–38.
stem/progenitor cells in human first-trimester fetal blood, liver, and bone 58. Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke
marrow. Blood. 2001;98(8):2396–402. in rat: neurotrophins and functional recovery. Neurology. 2002;59(4):514–23.
33. Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated source of 59. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells
stem cells for biotechnology. Trends Biotechnol. 2006;24(4):150–4. express a restricted set of functionally active chemokine receptors capable of
34. Mizuno H, Tobita M, Uysal AC. Concise review: adipose-derived stem cells as promoting migration to pancreatic islets. Blood. 2005;106(2):419–27.
a novel tool for future regenerative medicine. Stem Cells. 2012;30(5):804–10. 60. Son BR, Marquez-Curtis LA, Kucia M, et al. Migration of bone marrow and
35. De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cord blood mesenchymal stem cells in vitro is regulated by stromal-derived
cells from human adipose tissue and bone marrow. Cells Tissues Organs. factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves
2003;174(3):101–9. matrix metalloproteinases. Stem Cells. 2006;24(5):1254–64.
36. Haynesworth SE, Goshima J, Goldberg VM, et al. Characterization of cells 61. Ruster B, Gottig S, Ludwig RJ, et al. Mesenchymal stem cells display
with osteogenic potential from human marrow. Bone. 1992;13(1):81–8. coordinated rolling and adhesion behavior on endothelial cells. Blood. 2006;
37. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources 108(12):3938–44.
of postnatal human mesenchymal stem cells: candidate MSC-like cells from 62. Bi LK, Zhou N, Liu C, et al. Kidney cancer cells secrete IL-8 to activate Akt
umbilical cord. Stem Cells. 2003;21(1):105–10. and promote migration of mesenchymal stem cells. Urol Oncol. 2014;32(5):
38. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of 607–12.
mesenchymal stem cells of fetal or maternal origin from human placenta. 63. Bayo J, Real A, Fiore EJ, et al. IL-8, GRO and MCP-1 produced by
Stem Cells. 2004;22(7):1338–45. hepatocellular carcinoma microenvironment determine the migratory
39. He S, Gleason J, Fik-Rymarkiewicz E, et al. Human placenta-derived capacity of human bone marrow-derived mesenchymal stromal cells
mesenchymal stromal-like cells enhance angiogenesis via T cell-dependent without affecting tumor aggressiveness. Oncotarget. 2017;8(46):80235–48.
reprogramming of macrophage differentiation. Stem Cells. 2017;35(6):1603–13. 64. Saldana L, Bensiamar F, Valles G, et al. Immunoregulatory potential of
40. Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not mesenchymal stem cells following activation by macrophage-derived
immune privileged. Nat Biotechnol. 2014;32(3):252–60. soluble factors. Stem Cell Res Ther. 2019;10(1):58.
65. Eming SA, Wynn TA, Martin P. Inflammation and metabolism in tissue repair
and regeneration. Science. 2017;356(6342):1026–30.